NCT06308354 Colorectal Cancer Dataset in Xijing Hospital From 2011
| NCT ID | NCT06308354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xijing Hospital |
| Condition | Prognostic Cancer Model |
| Study Type | OBSERVATIONAL |
| Enrollment | 40,000 participants |
| Start Date | 2011-01-01 |
| Primary Completion | 2048-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40,000 participants in total. It began in 2011-01-01 with a primary completion date of 2048-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Eligibility Criteria
Inclusion Criteria: * 1\. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome; * 2\. Visit our center with complete medical records and pathological information; * 3\. Colorectal cancer patients diagnosed between 2013 and 2023. Exclusion Criteria: * 1\. The patient has other colorectal malignancies other than adenocarcinoma; * 2\. Malignant tumors adjacent to organs invading the colon and rectum; * 3\. Malignant tumors from distant organs metastasize to the colon and rectum; * 4\. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.
Frequently Asked Questions
Who can join the NCT06308354 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Prognostic Cancer Model. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06308354 currently recruiting?
Yes, NCT06308354 is actively recruiting participants. Visit ClinicalTrials.gov or contact Xijing Hospital to inquire about joining.
Where is the NCT06308354 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT06308354 clinical trial?
NCT06308354 is sponsored by Xijing Hospital. The trial plans to enroll 40,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.